Myoblasts for Survive 16 Weeks after Intracardiac Transfer and Start Differentiation

Abstract

Introduction: Skeletal myoblasts have been shown to survive transfer into myocardial scar tissue. The purpose of this study was to investigate differentiation after intramyocardial transplantation. Additionally, we evaluated an intravital fluorescence dye. Materials and Methods: Skeletal myoblasts were harvested from 8 male inbred Lewis rats and expanded in culture. For each transplantation planned, 10⁶ cells were trypsinized and incubated for three minutes with 2 ml of buffered PKH-26 solution (Sigma, St. Louis). This dye was integrated into the cell membrane. After washing three times, the cells were plated again for two more days. The cells were then transplanted into the hearts of 60 female Lewis-rats, mean weight 380 g (260 - 450 g). At implantation, 10⁶ cells suspended in 100 µl were injected into the apex region of the left ventricle. 12 animals served as the control group with only cell medium injected. Animals were sacrificed after 1, 2, 6, 8, 12, and 16 weeks (n = 10 each). The hearts were explanted and serial frozen sections of the hearts were prepared for detecting labeled cells. Sections with labeled cells were stained immunohistochemically for Myo D1 (myogenic origin), n-cam (early myotubes), desmin (muscular filament), myosin light chain (muscular contractile protein), and connexin 43 (tight junction). Results: Cell labeling was successful in all cases. After two days, the myoblasts had recovered from the staining procedure. The fluorescing dye, however, was only rarely transmitted by cell division. Marked cells were found in the intercellular spaces between the cardiac myofibers in at least 8 animals from each group. No fibrotic reaction or inflammation was seen surrounding the transplanted cells. Up to 6 weeks after implantation, the cells stained positive for n-cam and Myo D1, and particularly for desmin. More n-cam positive cells were found than labeled cells, indicating cell division after the cell transfer. Two animals suffered sudden death after a follow-up time of 8 and 10 weeks, which was possibly due to cardiac arrhythmia. After 8 weeks, the cells formed conglomerates and stained positive for desmin, myosin light chain, and connexin 43. The cells were not structurally integrated into the recipient myocardial tissue, however. Conclusions: Myoblasts divided further after transplantation into rat myocardium. Positive staining for desmin demonstrated the development of myofibers. Starting at 8 weeks after transplantation, the cells started differentiation without reaching structural integration during follow-up. Labeling the cells with PKH-26 proved to be a reliable method to detect the cells.

Myoblast transfer - myoblast transplantation - myocardial repair - myoblast differentiation

References

• 1 Walsh F S. N-cam is a target cell surface antigen for the purification of muscle cells for myoblast transfer therapy. In: Griggs R, Karpati G (eds) Myoblast Transfer Therapy. New York; Plenum Press 1990
• 2 Cifuentes-Diaz C, Nicolet M, Goudou D, Rieger F, Mege R M. N-cadherin and n-cam mediated adhesion in development and regeneration of skeletal muscle.  Neuromusc Dis. 1993;  3 361-365
• 3 Chiu R C-J, Zibaitis A, Kao R L. Cellular Cardiomyoplasty: myocardial regeneration with satellite cell implantation.  Ann Thorac Surg. 1995;  60 12-18
• 4 Murry C E, Wideman R W, Schwartz S M, Hauschka S D. Skeletal myoblast transplantation for repair of myocardial necrosis.  J Clin Invest. 1996;  98 2512-2523
• 5 Greentree D, Marelli D, Ma F, Chiu R C-J. Satellite cell transplantation for myocardial repair: labelling techniques.  Transplant Proc. 1994;  26 p3357
• 6 Zibaitis A, Greentree D, Ma F, Marelli D, Duong M, Chiu R C-J. Myocardial regeneration with satellite cell transplantation.  Transplant Proc. 1994;  26 p3294
• 7 Atkins B Z, Lewis C W, Kraus W E, Hutcheson K A, Glower D D, Taylor D A. Intrcardiac transplantation of skeletal myoblast yields two populations of striated cells in situ.  Ann Thorac Surg. 1999;  67 124-129
• 8 Taylor D A, Atkins B Z, Hungspreugs P, Jones T R, Reedy M C, Hutcheson K A, Glower D D, Kraus W E. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation.  Nature Medicine. 1998;  4 929-933
• 9 Dorfman J, Duong M, Zibaitis A, Pelletier M P, Shum-Tim D, Li C, Chiu R C-J. Myocardial tissue engineering with autologous myoblast implantation.  J Thorac Cardiovasc Surg. 1998;  116 744-751
• 10 Koh G Y, Klug M, Soonpa M H, Field L J. Differentiation and long-term survival of C2C12 myoblast grafts in hearts.  J Clin Invest. 1993;  92 1548-1554
• 11 Yoon P D, Kao R L, Magovern G J. Myocardial regeneration.  Tex Heart Inst J. 1995;  22 119-125
• 12 Suzuki K, Murtuza B, Heslop L, Morgan J E, Smolenski R T, Suzuki N, Partridge T A, Yacoub M H. Single fibers of skeletal muscle as a novel graft for cell transplantation to the heart.  J Thorac Cardiovasc Surg. 2002;  123 984-992
• 13 Suzuki K, Brand N J, Allen S, Khan M A, Farrell A O, Murtuza B, Oakley R E, Yacoub M H. Overexpression of connexin 43 in skeletal myoblasts: Relevance to cell transplantation to the heart.  J Thorac Cardiovasc Surg. 2001;  122 759-766
• 14 Pouzet B, Ghostine S, Vilquin J T, Garcin I, Scorsin M, Hagege A A, Duboc D, Schwartz K, Menasche P. Is skeletal myoblast transplantation clinically relevant in the era of angiotensin-converting enzyme inhibitors?.  Circulation. 2001;  104 1223-1228
• 15 Menasche P, Hagege A A, Scorsin M, Pouzet B, Desnos M, Duboc D, Schwartz K, Vilquin J T, Marolleau J P. Myoblast transplantation for heart failure.  Lancet. 2001;  357 279-280